Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Braunstein

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|July 1, 1997
Judgment day and a woman named MyrtleJ B Braunstein
Neurology|May 1, 1997
Meningiomas: the decision not to operateJ B Braunstein, N A Vick
The American Journal of Physiology|August 11, 1994
Assessment of ventricular relaxation in the developing chick embryo using a monoexponential modelJ B Braunstein, M Donovan, S Hughes, et al.
The New England Journal of Medicine|January 13, 2000
Unstable angina pectorisY Yeghiazarians, J B Braunstein, A Askari, et al.
Cardiology in Review|February 24, 2001
ABCs of cardiovascular disease risk managementJ B Braunstein, A Cheng, C Fakhry, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
Hepatobiliary excretion of bile acids and rose bengal in streptozotocin-induced and genetic diabetic ratsJ L Stone, J B Braunstein, T M Beaty, et al.
Chest|September 14, 2001
Lipid disorders: justification of methods and goals of treatmentJ B Braunstein, A Cheng, G Cohn, et al.
Clinical and Experimental Immunology|November 11, 1991
Sputum eosinophils from asthmatics express ICAM-1 and HLA-DRT T Hansel, J B Braunstein, C Walker, et al.
The Journal of Prevention of Alzheimer'S Disease|November 29, 2017
Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other TauopathiesT West, Y Hu, P B Verghese, et al.
The Journal of Prevention of Alzheimer'S Disease|June 25, 2023
Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task ForceD Angioni, O Hansson, R J Bateman, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|July 1, 1997
Judgment day and a woman named MyrtleJ B Braunstein
Neurology|May 1, 1997
Meningiomas: the decision not to operateJ B Braunstein, N A Vick
The American Journal of Physiology|August 11, 1994
Assessment of ventricular relaxation in the developing chick embryo using a monoexponential modelJ B Braunstein, M Donovan, S Hughes, et al.
The New England Journal of Medicine|January 13, 2000
Unstable angina pectorisY Yeghiazarians, J B Braunstein, A Askari, et al.
Cardiology in Review|February 24, 2001
ABCs of cardiovascular disease risk managementJ B Braunstein, A Cheng, C Fakhry, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
Hepatobiliary excretion of bile acids and rose bengal in streptozotocin-induced and genetic diabetic ratsJ L Stone, J B Braunstein, T M Beaty, et al.
Chest|September 14, 2001
Lipid disorders: justification of methods and goals of treatmentJ B Braunstein, A Cheng, G Cohn, et al.
Clinical and Experimental Immunology|November 11, 1991
Sputum eosinophils from asthmatics express ICAM-1 and HLA-DRT T Hansel, J B Braunstein, C Walker, et al.
The Journal of Prevention of Alzheimer'S Disease|November 29, 2017
Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other TauopathiesT West, Y Hu, P B Verghese, et al.
The Journal of Prevention of Alzheimer'S Disease|June 25, 2023
Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task ForceD Angioni, O Hansson, R J Bateman, et al.
Pageof 2